Abstract
AbstractThis study aims to provide a national overview of procedural sedation and analgesia practices within Pediatric Emergency Departments in Switzerland, focusing on the availability of pharmacologic agents, the presence of safety protocols, the utilization of non-pharmacological interventions, and to identify specific local limitations. We conducted a detailed subgroup analysis of Swiss data from a European cross-sectional survey on emergency department pediatric Procedural Sedation and Analgesia (PSA) practice, isolating data from Swiss sites. The survey, conducted between November 2019 and March 2020, covered various aspects of procedural sedation and analgesia practices. The survey included nine Swiss sites, treating a total of 252,786 patients in 2019. Topical analgesia, inhaled equimolar nitrous oxide-oxygen mixture, and ketamine were largely available. All sites had nurse-directed triage protocols in place; however, opioid administration was included in the protocols in only 66% of sites. Only 33% of hospitals reported common use of intravenous sedation. Barriers to procedural sedation and analgesia implementation included staffing shortages (89% of sites) and lack of dedicated spaces (78%).Conclusions: Despite a broad array of pharmacological and options available in Swiss Pediatric Emergency Departments, challenges remain in standardizing practices across the country. Limited space and staffing and enhancing training on non-pharmacological interventions were identified as potential areas for improving pain and anxiety management in pediatric emergency care. This study underscores the need for national guidelines to harmonize emergency department PSA practices across Switzerland, ensuring all children have access to effective and evidence-based procedural comfort.
What is Known:• Recent research, conducted in European emergency departments, suggests that in pediatric Procedural Sedation and Analgesia (PSA) resources are limited, and practice is heterogeneous
What is New:• Swiss pediatric hospitals offer a wide range of pharmacological options for pain and anxiety management. However, significant barriers to PSA were identified. These include external control of intravenous sedation and insufficient integration of non-pharmacological interventions, such as child life specialists and procedural hypnosis. National guidelines are needed to harmonize PSA practices
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Krauss B, Green SM (2006) Procedural sedation and analgesia in children. Lancet 367(9512):766–780
2. Nucci A, Sforzi I, Morley-Fletcher A, Saffirio C, Bussolin L, Masi S et al (2022) Quality improvement initiative using blended in situ simulation training on procedural sedation and analgesia in a pediatric emergency department: better patient care at lower costs. Simul Healthc 17(5):299–307
3. Sahyoun C, Cantais A, Gervaix A, Bressan S, Löllgen R, Krauss B (2021) Pediatric procedural sedation and analgesia in the emergency department: surveying the current European practice. Eur J Pediatr 180(6):1799–1813
4. Bevacqua M, Sforzi I, Bressan S, Barbi E, Sahyoun C (2023) Procedural sedation and analgesia in Italian pediatric emergency departments: a subgroup analysis in italian hospitals. Ital J Pediatr 49(1):23
5. Murphy A, O’Sullivan R, Wakai A, Grant TS, Barrett MJ, Cronin J et al (2014) Intranasal fentanyl for the management of acute pain in children. Cochrane Database Syst Rev 2014(10):Cd009942